Research / MYSZ / Fundamental state Inspectable configuration
State dimensions Filing 0001493152-26-037750 General Corporate
Capex intensity 10th Own-history percentile · N=10
Evidence method Level · gp.fundamentals.capex_revenue_ratio
0.03% · OPTIONAL · VALID
Operating cash generation 100th Own-history percentile · N=18
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
0.81% · OPTIONAL · VALID
Revenue growth 43th Own-history percentile · N=14
Evidence method Yoy · gp.fundamentals.revenue
53.04% · CORE · VALID
Inventory pressure 24th Own-history percentile · N=17
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
63.88% · OPTIONAL · VALID
Gross margin 22th Own-history percentile · N=18
Evidence method Level · gp.fundamentals.gross_margin
31.69% · CORE · VALID
Operating margin 67th Own-history percentile · N=18
Evidence method Level · gp.fundamentals.operating_margin
-56.09% · CORE · VALID
R&D intensity 56th Own-history percentile · N=18
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
12.21% · OPTIONAL · VALID
SBC intensity 17th Own-history percentile · N=18
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
2.87% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 19 states Self-history eligible
Dec 31, 2021 0/6 normalized Level 3 Mar 31, 2022 0/7 normalized Level 3 Jun 30, 2022 0/7 normalized Level 3 Sep 30, 2022 0/7 normalized Level 3 Dec 31, 2022 0/8 normalized Level 3 Mar 31, 2023 0/7 normalized Level 3 Jun 30, 2023 0/7 normalized Level 3 Sep 30, 2023 0/7 normalized Level 3 Dec 31, 2023 5/8 normalized Level 3 Mar 31, 2024 6/7 normalized Level 3 Jun 30, 2024 6/7 normalized Level 3 Sep 30, 2024 6/7 normalized Level 3 Dec 31, 2024 7/8 normalized Level 3 Mar 31, 2025 7/7 normalized Level 3 Jun 30, 2025 7/7 normalized Level 3 Sep 30, 2025 7/8 normalized Level 3 Dec 31, 2025 8/8 normalized Level 3 Mar 31, 2026 8/8 normalized Level 3 Jun 30, 2026 8/8 normalized Level 4 Period transition
What moved in the state? Capex Intensity Decreased
Previous 1.92%
Current 0.03%
Delta -1.89% Cash Generation Increased
Previous -86.42%
Current 0.81%
Delta 87.24% Growth Decreased
Previous 61.87%
Current 53.04%
Delta -8.83% Inventory Pressure Decreased
Previous 142.48%
Current 63.88%
Delta -78.61% Margin Decreased
Previous 39.26%
Current 31.69%
Delta -7.57% Profitability Increased
Previous -58.73%
Current -56.09%
Delta 2.64% R And D Intensity Increased
Previous 9.98%
Current 12.21%
Delta 2.23% Sbc Intensity Decreased
Previous 3.76%
Current 2.87%
Delta -0.89% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Dec 31, 2025
Similarity 76%
Compared 8 dimensions
Coverage 100% Growth 17.9 · Margin 2.8 · Profitability 4.2 · Sbc Intensity 33.3 · Capex Intensity 27.5 · Cash Generation 37.5 · R And D Intensity 24.3 · Inventory Pressure 16.9 Dec 31, 2023
Similarity 74%
Compared 5 dimensions
Coverage 63% Margin 27.8 · Profitability 20.8 · Sbc Intensity 8.3 · Cash Generation 12.5 · R And D Intensity 43.1 Dec 31, 2024
Similarity 73%
Compared 7 dimensions
Coverage 88% Growth 30.4 · Margin 44.4 · Profitability 16.7 · Sbc Intensity 8.3 · Cash Generation 16.7 · R And D Intensity 38.9 · Inventory Pressure 14.4 Jun 30, 2024
Similarity 66%
Compared 6 dimensions
Coverage 75% Margin 57.8 · Profitability 23.3 · Sbc Intensity 6.7 · Cash Generation 0.0 · R And D Intensity 45.6 · Inventory Pressure 32.0 Jun 30, 2025
Similarity 64%
Compared 7 dimensions
Coverage 88% Growth 22.9 · Margin 63.5 · Profitability 33.3 · Sbc Intensity 9.5 · Cash Generation 28.6 · R And D Intensity 19.8 · Inventory Pressure 45.7 Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.